Cui et al. [22] also demonstrated that B cells promote the differentiation of tumor-specific Tfh cells in a neoantigen-dependent manner, which in turn enhances the effector function of CD8+ T cells by producing IL-21 and drives anti-tumor immunity in a murine model of lung adenocarcinoma. This evidence concerns the gene CD8A and lung adenocarcinoma.